Literature DB >> 2079082

Respiratory deterioration during growth hormone therapy in a case of congenital nemaline myopathy.

K Logghe1, J M Wit, F Jennekens, J E Pruijs.   

Abstract

Congenital nemaline myopathy (CNM) is generally classified as a non-progressive or slowly progressive neuromuscular disease. We describe a boy with CNM and an isolated partial growth hormone (GH) deficiency. From the onset of GH therapy his respiratory capacity deteriorated rapidly. The possible association between this deterioration and GH therapy is discussed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2079082     DOI： 10.1007/BF01959486

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

1.  Nocturnal hypoventilation in children with nonprogressive neuromuscular disease.

Authors:  J Z Heckmatt; L Loh; V Dubowitz
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

2.  Nemaline myopathy as a cause of sleep hypoventilation.

Authors:  C Maayan; C Springer; Y Armon; E Bar-Yishay; Y Shapira; S Godfrey
Journal:  Pediatrics       Date:  1986-03       Impact factor: 7.124

3.  Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency: a five years follow-up.

Authors:  M Zatz; R T Betti
Journal:  Am J Med Genet       Date:  1986-07

Review 4.  Hormonal control of muscle growth.

Authors:  J R Florini
Journal:  Muscle Nerve       Date:  1987-09       Impact factor: 3.217

5.  Familial deficiency of growth hormone and spinal muscular atrophy.

Authors:  J G Leroy; M M Craen
Journal:  Prog Clin Biol Res       Date:  1985

6.  Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.

Authors:  M Zatz; R T Betti; O Frota-Pessoa
Journal:  Am J Med Genet       Date:  1986-07

7.  Nemaline myopathy associated with hypertrophic cardiomyopathy.

Authors:  C L Van Antwerpen; S M Gospe; M P Dentinger
Journal:  Pediatr Neurol       Date:  1988 Sep-Oct       Impact factor: 3.372

8.  Human growth hormone and estrogens in boys with Duchenne muscular dystrophy.

Authors:  S B Chyatte; D Rudman; J H Patterson; G G Gerron; I O'Beirne; J Barlow; A Jordan; J S Shavin
Journal:  Arch Phys Med Rehabil       Date:  1973-06       Impact factor: 3.966

9.  Congenital nemaline myopathy. A clinical follow-up of twelve patients.

Authors:  C Wallgren-Pettersson
Journal:  J Neurol Sci       Date:  1989-01       Impact factor: 3.181

10.  Congenital nemaline myopathy. II. Quantitative changes in alpha-actinin and myosin in skeletal muscle.

Authors:  I Stuhlfauth; F G Jennekens; J Willemse; B M Jockusch
Journal:  Muscle Nerve       Date:  1983-01       Impact factor: 3.217
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.